These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7696730)

  • 21. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium.
    Khoukaz G; Gross NJ
    Am J Respir Crit Care Med; 1999 Sep; 160(3):1028-30. PubMed ID: 10471636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we justify ipratropium therapy as initial management of acute exacerbations of COPD?
    Demirkan K; Kuhl D; Headley AS; Self T
    Pharmacotherapy; 1999 Jul; 19(7):838-43. PubMed ID: 10417032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of acute, severe asthma in children.
    Streetman DD; Bhatt-Mehta V; Johnson CE
    Ann Pharmacother; 2002; 36(7-8):1249-60. PubMed ID: 12086560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nebulization in worsening of chronic obstructive lung diseases: importance of anticholinergic agents. The Multicenter Group].
    Cuvelier A; Muir JF
    Ann Fr Anesth Reanim; 1998; 17 Suppl 2():48s-51s. PubMed ID: 9881209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
    Karpel JP
    Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis.
    Castro-Rodriguez JA; Rodrigo GJ
    J Pediatr; 2004 Aug; 145(2):172-7. PubMed ID: 15289762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inspiratory flow rate on beta2-agonist induced bronchodilation in mechanically ventilated COPD patients.
    Mouloudi E; Prinianakis G; Kondili E; Georgopoulos D
    Intensive Care Med; 2001 Jan; 27(1):42-6. PubMed ID: 11280671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug treatment of COPD. Controversies about agents and how to deliver them.
    Simon PM; Statz EM
    Postgrad Med; 1992 Mar; 91(4):473-9. PubMed ID: 1347654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spacers and nebulisers for the delivery of beta-agonists in non-life-threatening acute asthma.
    Cates C
    Respir Med; 2003 Jul; 97(7):762-9. PubMed ID: 12854625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction.
    Mestitz H; Copland JM; McDonald CF
    Chest; 1989 Dec; 96(6):1237-40. PubMed ID: 2582827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchodilator therapy for chronic obstructive pulmonary disease.
    Lu CC
    Respirology; 1997 Dec; 2(4):317-22. PubMed ID: 9525304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal pharmacologic treatment of the critically ill patient with obstructive airways disease.
    Siefkin AD
    Am J Med; 1996 Jan; 100(1A):54S-61S. PubMed ID: 8610719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of regular use of high-dose nebulized beta2-agonists on resting energy expenditure, weight, and handgrip strength in patients with chronic airflow limitation.
    Congleton J; Muers MF
    Chest; 1998 Jun; 113(6):1588-94. PubMed ID: 9631798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease.
    Cydulka RK; Emerman CL
    Ann Emerg Med; 1995 Apr; 25(4):470-3. PubMed ID: 7710150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD.
    Berry RB; Shinto RA; Wong FH; Despars JA; Light RW
    Chest; 1989 Dec; 96(6):1241-6. PubMed ID: 2582828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options.
    Friedman M; Hilleman DE
    Pharmacoeconomics; 2001; 19(3):245-54. PubMed ID: 11303413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Izumi T
    Drugs Aging; 1998 Feb; 12(2):129-37. PubMed ID: 9509291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
    Teramoto S; Fukuchi Y; Ouchi Y
    Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.